Orally active inhibitors of stromelysin-1 (MMP-3)
- 1 April 1996
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 6 (7) , 803-806
- https://doi.org/10.1016/0960-894x(96)00109-6
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Inhibition of matrix metalloproteinases by P1 substituted N-carboxyalkyl dipeptidesBioorganic & Medicinal Chemistry Letters, 1996
- Proteoglycan-Degrading Activity of Human Stromelysin-1 and Leukocyte Elastase in Rabbit Joints. Quantitation of Proteoglycan and a Stromelysin-lnduced HABR Fragment of Aggrecan in Synovial Fluid and CartilageConnective Tissue Research, 1996
- Stromelysin‐1: Three‐dimensional structure of the inhibited catalytic domain and of the C‐truncated proenzymeProtein Science, 1995
- Inhibition of matrix metalloproteinases by N-carboxyalkyl dipeptides: Enhanced potency and selectivity with substituted P1′ homophenylalaninesBioorganic & Medicinal Chemistry Letters, 1995
- 1.56 Å structure of mature truncated human fibroblast collagenaseProteins-Structure Function and Bioinformatics, 1994
- Inhibition of matrix metalloproteinases by N-carboxyalkyl peptidesJournal of Medicinal Chemistry, 1993
- Matrix metalloproteinases and their inhibitors in connective tissue remodelingThe FASEB Journal, 1991
- In vivo activity of human recombinant tissue inhibitor of metalloproteinases (TIMP)Biochemical Pharmacology, 1990
- A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization.Journal of Biological Chemistry, 1986